These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19635858)

  • 1. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.
    Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjöstrand M; Eloranta ML; Ní Gabhann J; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
    J Exp Med; 2009 Aug; 206(8):1661-71. PubMed ID: 19635858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
    Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice.
    Bolland S; Garcia-Sastre A
    J Exp Med; 2009 Aug; 206(8):1647-51. PubMed ID: 19635865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.
    Gómez-Martín D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juárez-Vega G; Torres-Ruiz J; Alcocer-Varela J
    Clin Exp Immunol; 2017 Apr; 188(1):154-162. PubMed ID: 27936488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
    Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
    Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
    Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
    Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages.
    Kong HJ; Anderson DE; Lee CH; Jang MK; Tamura T; Tailor P; Cho HK; Cheong J; Xiong H; Morse HC; Ozato K
    J Immunol; 2007 Jul; 179(1):26-30. PubMed ID: 17579016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.
    Hsu CH; Yu YL
    Cancer Cell Int; 2023 Nov; 23(1):289. PubMed ID: 37993883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review.
    Oke V; Wahren-Herlenius M
    J Autoimmun; 2012 Aug; 39(1-2):77-82. PubMed ID: 22402340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
    Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
    J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
    Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
    Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
    Espinosa A; Hennig J; Ambrosi A; Anandapadmanaban M; Abelius MS; Sheng Y; Nyberg F; Arrowsmith CH; Sunnerhagen M; Wahren-Herlenius M
    J Biol Chem; 2011 Oct; 286(42):36478-91. PubMed ID: 21862588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro52/TRIM21 - From host defense to autoimmunity.
    Holwek E; Opinc-Rosiak A; Sarnik J; Makowska J
    Cell Immunol; 2023; 393-394():104776. PubMed ID: 37857191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
    Chan EKL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
    Lee AYS
    Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.
    Yoshimi R; Chang TH; Wang H; Atsumi T; Morse HC; Ozato K
    J Immunol; 2009 Jun; 182(12):7527-38. PubMed ID: 19494276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.
    Scapini P; Lamagna C; Hu Y; Lee K; Tang Q; DeFranco AL; Lowell CA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):E823-32. PubMed ID: 21911371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.
    Yoshimi R; Ishigatsubo Y; Ozato K
    Int J Rheumatol; 2012; 2012():718237. PubMed ID: 22701487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RORγt expression in T
    Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
    Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.